Table 1: Disease status at the time of sampling.

From: Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

Patients with one time point511NANANANA52
Patients with two time points112013NANA26
Patients with three time points0202026
  1. For each group of patients (that is, those with one sample only, and those with two and three serial samples), the number of samples are plotted in relation to treatment received before sampling.